Shah Rukh Khan condoles death of cancer-stricken fan

Twitter started a campaign titled #SRKmeetsAruna to honour the wish of the late patient to meet the King Khan


Ians October 25, 2017
PHOTO: INDIAN EXPRESS

Shah Rukh Khan on Tuesday condoled the death of cancer patient Aruna PK, whose "last wish" was to meet the superstar.

The news of her death was shared by her son Akshat Khot on Twitter on Tuesday. She was 60, and had been battling cancer for six years.

I wear my superstardom on my sleeve and enjoy it: Shah Rukh Khan

Shah Rukh tweeted, "May Allah give you strength to deal with the loss of your beautiful mother. I know how sad it is to deal with the loss of a parent. Know that she is always with you and henceforth do things that give her reasons to smile in heaven."



Akshat tweeted, "Thank You SRK for giving her happiness in her final moments."



On his message of condolence, Akshat wrote, "Thank You so much sir. God bless you!"

Aruna's wish had first come to the actor's notice when well-wishers of the cancer patient united to start a Twitter campaign titled #SRKmeetsAruna by reportedly sharing images of the 60-year-old on a hospital bed.

Earlier, he had taken to social media to send a video message to Aruna.

Shah Rukh's latest pic with Suhana will make daughters green with envy

"I'm made to understand through your son Akshat and daughter Priyanka that you are fighting with an illness. I want to say this that I, my whole family, all our friends whoever knows you, we are praying for your wellness," he had said.


Shah Rukh had promised Aruna that he would meet her soon and will also perform for her.

"You are in a state where meeting you is perhaps not a possibility. I know this for a fact, with the positivity that you carry around that you will get well soon and we will meet very soon," he had said.

Have something to add to the story? Share it in the comments below.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ